Correction: Neoadjuvant and/or adjuvant immune checkpoint inhibitors combined with chemotherapy for locally advanced resectable penile squamous cell carcinoma - Summary - MDSpire

Correction: Neoadjuvant and/or adjuvant immune checkpoint inhibitors combined with chemotherapy for locally advanced resectable penile squamous cell carcinoma

  • By

  • Shanshan Xu

  • Feiran Chen

  • Lei Diao

  • Weiyu. Wang

  • Xuemin Wang

  • Qiong Wu

  • Peipei Sun

  • Yating Hao

  • Yuqian Wang

  • Rongjie Ji

  • Yanan Jiang

  • Jun Du

  • Bing Ang

  • Zhigang Zhao

  • Qing Yang

  • April 30, 2026

  • 0 min

Share

Objective:

To correct errors in the author list and affiliation in the published article regarding the treatment of locally advanced resectable penile squamous cell carcinoma.

Key Findings:
  • The author list was incorrectly ordered in the original publication, which could mislead future citations.
  • The department affiliation was misidentified in the original article, impacting institutional representation.
Interpretation:

The corrections ensure proper attribution of authorship and accurate representation of institutional affiliations, which is crucial for academic integrity.

Limitations:
  • The article does not address any clinical findings or outcomes related to the treatment of penile squamous cell carcinoma, which limits its applicability.
Conclusion:

The original article has been updated to reflect these corrections, which are essential for maintaining the integrity of academic references.

Original Source(s)

Correction: Neoadjuvant and/or adjuvant immune checkpoint inhibitors combined with chemotherapy for locally advanced resectable penile squamous cell carcinoma

  • by Shanshan Xu, Feiran Chen, Lei Diao, Weiyu. Wang, Xuemin Wang, Qiong Wu, Peipei Sun, Yating Hao, Yuqian Wang, Rongjie Ji, Yanan Jiang, Jun Du, Bing Ang, Zhigang Zhao, Qing Yang

  • April 30, 2026

Related Content

Recurrent IDH-mutant astrocytoma WHO grade 4 diagnosed during pregnancy: case report with literature review

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant

Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report